Cleared Traditional

K192418 - Phacoemulsification Needle (Tip) and Ir...

K192418 is the FDA 510(k) clearance for Phacoemulsification Needle (Tip) and Ir... by Raico, LLC. It is a Class 2 Ophthalmic device (product code HQC) cleared through the Traditional 510(k) pathway after a 266-day FDA review.

K192418 · Raico, LLC · Ophthalmic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2020
Decision
266d
Days
Class 2
Risk

K192418 is an FDA 510(k) clearance for the Phacoemulsification Needle (Tip) and Irrigation Sleeve. Classified as Unit, Phacofragmentation (product code HQC), Class II - Special Controls.

Submitted by Raico, LLC (Westmont, US). The FDA issued a Cleared decision on May 27, 2020 after a review of 266 days - an extended review cycle.

This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 886.4670 - the FDA ophthalmic device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Ophthalmic review framework, consistent with the majority of Class II 510(k) submissions.

View all Raico, LLC devices

Submission Details

510(k) Number K192418 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 04, 2019
Decision Date May 27, 2020
Days to Decision 266 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
156d slower than avg
Panel avg: 110d · This submission: 266d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code HQC Unit, Phacofragmentation
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 886.4670
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Ophthalmic devices follow this clearance model.

Regulatory Peers - HQC Unit, Phacofragmentation

All 80
Devices cleared under the same product code (HQC) and FDA review panel - the closest regulatory comparables to K192418.
xPORT S Lens Fragmentation System
K200207 · Carl Zeiss Meditec Cataract Technology, Inc. · Oct 2020
xPORT 304 (miCOR) System Lens Fragmentation System
K200584 · Carl Zeiss Meditec Cataract Technology, Inc. · Jul 2020
Visalis V500, Visalis S500
K193376 · Carl Zeiss Meditec, AG · Jun 2020
LEGION System
K191650 · Alcon Research, LLC · Nov 2019
EVA, anterior machine, EVA, combined machine, EVA combined machine with laser (DORC connector), EVA combined machine with laser (SMA connector)
K190875 · D.O.R.C. Dutch Ophthalmic Research Center (International) · Sep 2019
COMPACT INTUITIV System, COMPACT INTUITIV Wireless Remote Control, COMPACT INTUITIV Four-Button Foot Pedal, COMPACT INTUITIV Closed-Toe Foot Pedal
K191933 · Johnson & Johnson Surgical Vision, Inc. · Aug 2019